Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Joint cell discovery offers new hope for people with rheumatoid arthritis

General Research

The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long-term remission.

UK regulator gives green light to clinical trial of hydroxychloroquine to prevent Covid-19 in healthcare workers

Clinical Trials Coronavirus COVID-19 General

The UK regulator MHRA announced on 26 June that it would again permit recruitment to the COPCOV COVID-19 prevention clinical trial. The MHRA decision came 5 weeks after it reacted immediately to the now-discredited paper published in The Lancet suggesting harms with hydroxychloroquine, and paused recruitment of UK participants. But The Lancet paper was based on fabricated data and was swiftly retracted. After this interruption, recruitment around the globe to COPCOV can now resume.

Varying risk of COVID-19 to health workers revealed

Coronavirus COVID-19 General Research

A study at Oxford University Hospitals (OUH) NHS Foundation Trust has revealed the different levels of risk faced by healthcare workers dealing with the COVID-19 pandemic.

Trial of Oxford COVID-19 vaccine starts in Brazil

Clinical Trials Coronavirus COVID-19 General

Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19.

New Oxford co-led platform to accelerate COVID-19 tests into real-world use

Coronavirus COVID-19 General Research

Testing for coronavirus infection could become quicker, more convenient and more accurate, following the launch of a multicentre national programme of research that will evaluate how new diagnostic tests perform in hospitals, general practices and care homes.

The Duke of Cambridge visits Oxford Vaccine Centre

Coronavirus COVID-19 General Research

The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19.

Theolytics announced winners of the Santander Pitch Finale

General Innovation

Following a fantastic event, Theolytics was announced the winner of the BioEscalator’s inaugural Pitch Finale, which was kindly supported by Santander Universities UK.

Trial of Oxford COVID-19 vaccine in South Africa begins

Clinical Trials Coronavirus COVID-19 General

Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week.

Oxford leads development of risk prediction model for more tailored COVID-19 shielding advice

Coronavirus COVID-19 General Research

Clinicians and GPs will soon be able to better identify patients who are at a higher risk of serious illness from SARS-CoV-2 infection based on a new data-driven risk prediction model, now under development by an Oxford University-led team.

Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science

Awards and Appointments General Research

Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.

Assumptions on fetal iron development during pregnancy challenged

General Research

A key hormone in the fetal liver has been found for the first time to play a critical role in determining iron endowment in the newborn baby.

NDORMS professor awarded prestigious Carol Nachman prize for Rheumatology

Awards and Appointments General Research

Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.

Oxford University collaborate with Bvlgari to fight COVID-19 and future pandemics

Clinical Trials Coronavirus COVID-19 General

Bvlgari, the Italian luxury brand, has today announced plans to support research into COVID-19 and vaccine development at Oxford University.

Children show increase in mental health difficulties over COVID-19 lockdown

Coronavirus COVID-19 General Research

More than 10,000 parents have now taken part in the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) survey led by experts at the University of Oxford.

Dexamethasone reduces death in hospitalised patients with severe respiratory

Clinical Trials Coronavirus COVID-19 General Research

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment). Over 11,500 patients have been enrolled from over 175 NHS hospitals in the UK.

New partnership aims to significantly reduce the incidence of hip and vertebral fractures

General Innovation Research

The Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

Clinical Trials Coronavirus COVID-19 General

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020.

Oxford to collaborate on AI algorithms to help predict COVID-19 severity in patients

Coronavirus COVID-19 General Research

The University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) in the UK is collaborating with GE Healthcare to develop and test algorithms to aid in the diagnosis and management of COVID-19 pneumonia.

Oxford researchers lead international study on effects of COVID-19 on sleep

Coronavirus COVID-19 General Research

An international group of researchers led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

Load More